These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 16395299

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Ghrelin receptor antagonism attenuates nicotine-induced locomotor stimulation, accumbal dopamine release and conditioned place preference in mice.
    Jerlhag E, Engel JA.
    Drug Alcohol Depend; 2011 Sep 01; 117(2-3):126-31. PubMed ID: 21310553
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Inhibition of MAO-A activity enhances behavioural activity of rats assessed using water maze and open arena tasks.
    Barbelivien A, Nyman L, Haapalinna A, Sirviö J.
    Pharmacol Toxicol; 2001 Jun 01; 88(6):304-12. PubMed ID: 11453370
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Serotonergic mechanism underlying tranylcypromine enhancement of nicotine self-administration.
    Villégier AS, Belluzzi JD, Leslie FM.
    Synapse; 2011 Jun 01; 65(6):479-89. PubMed ID: 20936688
    [Abstract] [Full Text] [Related]

  • 31. Effects of adolescent treatment with nicotine, harmane, or norharmane in male Sprague-Dawley rats.
    Goodwin AK, Lantz-McPeak SM, Robinson BL, Law CD, Ali SF, Ferguson SA.
    Neurotoxicol Teratol; 2015 Jun 01; 47():25-35. PubMed ID: 25450662
    [Abstract] [Full Text] [Related]

  • 32. Comparison of the effects of bupropion and nicotine on locomotor activation and dopamine release in vivo.
    Sidhpura N, Redfern P, Rowley H, Heal D, Wonnacott S.
    Biochem Pharmacol; 2007 Oct 15; 74(8):1292-8. PubMed ID: 17678630
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Acute inhibition of cardiac monoamine oxidase A after tobacco smoke inhalation: validation study of [11C]befloxatone in rats followed by a positron emission tomography application in baboons.
    Valette H, Bottlaender M, Dollé F, Coulon C, Ottaviani M, Syrota A.
    J Pharmacol Exp Ther; 2005 Jul 15; 314(1):431-6. PubMed ID: 15833896
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Effects of Monoamine Oxidase Inhibition on the Reinforcing Properties of Low-Dose Nicotine.
    Smith TT, Rupprecht LE, Cwalina SN, Onimus MJ, Murphy SE, Donny EC, Sved AF.
    Neuropsychopharmacology; 2016 Aug 15; 41(9):2335-43. PubMed ID: 26955970
    [Abstract] [Full Text] [Related]

  • 39. Voluntary ethanol intake in the rat: effects of nicotinic acetylcholine receptor blockade or subchronic nicotine treatment.
    Blomqvist O, Ericson M, Johnson DH, Engel JA, Söderpalm B.
    Eur J Pharmacol; 1996 Oct 31; 314(3):257-67. PubMed ID: 8957244
    [Abstract] [Full Text] [Related]

  • 40. [Hypertensive crises with reversible inhibitors of monoamine oxidases? Results of tyramine interaction studies].
    Bieck PR.
    Psychiatr Prax; 1989 Aug 31; 16 Suppl 1():25-31. PubMed ID: 2587674
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.